Steven Ruben has been appointed vice president for protein therapeutics at Celera Genomics. He will lead target discovery programs for therapeutic antibodies and oversee the company’s cell biology, protein chemistry, and mass spectrometry efforts. He joins Celera from Human Genome Sciences, where he was vice president for research.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
